David Bassa
CEO
Your CSV is on the way
We’ve sent your CSV file to email@email.com
Claimed by
owner Add to list
Cannalean Biotechs
Former names:
CBD-based Solutions for Treating Dyslipidemia
Stealth Mode
Cannalean Biotechs
Cannalean Biotechs Overview
CannaLean Biotechs is committed to the research and development of a proprietary formulation of cannabidiol (CBD) and chitosan that can potentially benefit millions of patients with dyslipidemia.
CannaLean uses a synthetic form of CBD, a non-psychotropic component of cannabis, with chitosan, a biocompatible, non-toxic, and non-immunogenic compound that enhances the potential of CBD to reduce lipid blood levels. The company's preliminary results show the effect of the formulation on cholesterol and triglyceride reduction.
CannaLean Biotechs was established in partnership with Mor Research Applications.
CannaLean uses a synthetic form of CBD, a non-psychotropic component of cannabis, with chitosan, a biocompatible, non-toxic, and non-immunogenic compound that enhances the potential of CBD to reduce lipid blood levels. The company's preliminary results show the effect of the formulation on cholesterol and triglyceride reduction.
CannaLean Biotechs was established in partnership with Mor Research Applications.
Cumulative Funding Raised Over Time ($)
Employees Over Time
Cannalean Biotechs Climate Tech relevance
null
No Data, yet.
Sorry, no content found under this section.
Jan 20, 2026
www.prnewswire.com
/PRNewswire/ -- CannaLean Biotechs Ltd., a clinical-stage biotechnology company developing a patented cannabidiol–chitosan (CBD–CHT) formulation for...
#Product Stage #Partners
Jun 21, 2022
www.prnewswire.com
CannaLean Biotechs Announces a Phase 2a Clinical Trial of Cannabidiol-Based Formulation for Lowering Blood Cholesterol Levels
#Investment #Expand
Sep 16, 2019
www.healtheuropa.eu
Lower blood lipids: can you eat a cheeseburger and have a strong heart?
undefined
Nov 26, 2018
www.prnewswire.com
CannaLean Develops New Cannabidiol & Chitosan Formulation to Safely Lower Cholesterol and Triglyceride Levels;A Stain Alternative With Fewer Risks
#Customers
Companies you might be interested in
Driven by Finder AI
-
CannAssure TherapeuticsMedical Cannabis Products1-10 employees • Funding Stage: Public
shared sectors
Also shared
Are these companies similar? -
ImPact BiotechTargeted Treatment for Selective Tumor Ablation11-50 employees • Funding Stage: Pre-Funding
shared sectors
Also shared
Are these companies similar? -
EndorTechSynthetic Beta‑Endorphin Aerosol Platform for Pain ReliefAre these companies similar? -
DenovAI BiotechDynamic Protein Design11-50 employees • Funding Stage: Seed
shared sectors
Also shared
Are these companies similar?
Primary sector
Total funding
Funding stage
Number of employees
Founded
Related Content
Lists. Maps. Reports
Team Members
DB
OA
DR
PM
DP
DB
Contact Team
Affiliated Organizations
(null)Web & social links
https://www.cannaleanbio.com
Locations
Israel
Baruch Hirsch Street 14, Bnei Brak, Israel
Offices Abroad
Photos & videos
(1)No Data, yet.
Sorry, no content found under this section.
Introducing CannaLean - Revolutionizing the Future of Cannabis
Cannalean Biotechs Business
Sector
Primary:
Health Tech & Life Sciences
Target Customer
Core Technology
Use Cases
(0)Tech Community Involvement
(0)Cannalean Biotechs Financials
Cumulative Funding Raised Over Time ($)
No Data, yet.
Sorry, no content found under this section.
Public Offerings & Exits
Private Equity Funding
Non-Equity Funding
Mergers and Acquisitions
Cannalean Biotechs Lifecycle
Cumulative Funding Raised Over Time ($)
Timeline
Employees Over Time
News Over Time
No Data, yet.
Sorry, no content found under this section.
Program
Mar 2019
Hub
Name
BioSeedXL
Batch
1
Cannalean Biotechs News
News Over Time
No Data, yet.
Sorry, no content found under this section.
News Articles
Jan 20, 2026
www.prnewswire.com
/PRNewswire/ -- CannaLean Biotechs Ltd., a clinical-stage biotechnology company developing a patented cannabidiol–chitosan (CBD–CHT) formulation for...
#Product Stage #Partners
Jun 21, 2022
www.prnewswire.com
CannaLean Biotechs Announces a Phase 2a Clinical Trial of Cannabidiol-Based Formulation for Lowering Blood Cholesterol Levels
#Investment #Expand
Sep 16, 2019
www.healtheuropa.eu
Lower blood lipids: can you eat a cheeseburger and have a strong heart?
undefined
Nov 26, 2018
www.prnewswire.com
CannaLean Develops New Cannabidiol & Chitosan Formulation to Safely Lower Cholesterol and Triglyceride Levels;A Stain Alternative With Fewer Risks
#Customers
Related Content
Cannalean Biotechs Team
No Data, yet.
Sorry, no content found under this section.
Employees Over Time
Companies you might be interested in
Driven by Finder AI
-
CannAssure TherapeuticsMedical Cannabis Products1-10 employees • Funding Stage: Public
shared sectors
Also shared
Are these companies similar? -
ImPact BiotechTargeted Treatment for Selective Tumor Ablation11-50 employees • Funding Stage: Pre-Funding
shared sectors
Also shared
Are these companies similar? -
EndorTechSynthetic Beta‑Endorphin Aerosol Platform for Pain ReliefAre these companies similar?
-
DenovAI BiotechDynamic Protein Design11-50 employees • Funding Stage: Seed
shared sectors
Also shared
Are these companies similar?
Cannalean Biotechs Internal
Create note
Notes
(undefined)
Filter notes
Content Writer
undefined
BI Verification
undefined
Phone Number
undefined
Israel Register ID
undefined
Confidence Score
undefined
Missing Fields
undefined
Profile Creator
undefined
Profile Update
undefined
undefined
Access Comprehensive Financial Analytics
Create a free account to:
- Explore detailed financial analytics.
- Track company growth and size.
- Connect with company team members.
I already have access,
I already have access,